Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case seriesKevin Keith, Carey K. Anders, Yueh Z. Lee et al.|Cancer Treatment Communications|2016Cited by 43
Changing Natural History of HER2–Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted TherapiesLouisa A. Mounsey, Carey K. Anders, Lisa A. Carey et al.|Clinical Breast Cancer|2017Cited by 42
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina ExperienceMegan Jean McKee, Timothy M. Zagar, Kevin Keith et al.|The Oncologist|2015Cited by 34
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J. Sambade, Carey K. Anders, Grace Prince et al.|Breast Cancer Research and Treatment|2019Cited by 23
A changing natural history of HER2-positive breast cancer metastatic to the brain in the era of new, targeted therapies.Louisa A. Mounsey, Carey K. Anders, Julia M. Benbow et al.|Journal of Clinical Oncology|2016Cited by 4